Aspirin 75mg gastro-resistant tablets

Land: Verenigd Koninkrijk

Taal: Engels

Bron: MHRA (Medicines & Healthcare Products Regulatory Agency)

Werkstoffen:

Aspirin

Beschikbaar vanaf:

Actavis UK Ltd

ATC-code:

B01AC06

INN (Algemene Internationale Benaming):

Aspirin

Dosering:

75mg

farmaceutische vorm:

Gastro-resistant tablet

Toedieningsweg:

Oral

klasse:

No Controlled Drug Status

Prescription-type:

Valid as a prescribable product

Product samenvatting:

BNF: 02090000; GTIN: 5012617012425 5012617012340

Bijsluiter

1
Actavis Logo
PACKAGE LEAFLET: INFORMATION FOR THE USER
ASPIRIN 75MG GASTRO-RESISTANT TABLETS
acetylsalicylic acid
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if
their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects
not listed in this leaflet. See section 4.
-
The full name of this medicine is
Aspirin 75mg Gastro-resistant Tablets
but within the leaflet it will
be referred to as Aspirin tablets.
WHAT IS IN THIS LEAFLET
:
1.
What Aspirin tablets are and what they are used for
2.
What you need to know before you take Aspirin tablets.
3.
How to take Aspirin tablets.
4.
Possible side effects
5.
How to store Aspirin tablets.
6.
Contents of the pack and other information
1.
WHAT ASPIRIN TABLETS ARE AND WHAT THEY ARE USED FOR
Aspirin tablets contain acetylsalicylic acid, which in low doses
belong to a group of medicines called anti-
platelet agents. Platelets are tiny cells in the blood that cause the
blood to clot and are involved in
thrombosis. When a blood clot occurs in an artery it stops the blood
flowing and cuts off the oxygen supply.
When this happens in the heart it can cause a heart attack or angina;
in the brain it can cause a stroke.
Aspirin tablets are taken to reduce the risk of blood clots forming
and thereby prevent further:
-
heart attacks
-
strokes
-
cardiovascular problems in patients who suffer from stable or unstable
angina (a type of chest pain).
Aspirin tablets are also used to prevent the formation of blood clots
after certain types of heart surgery in
order to widen or to unblock the blood vessels.
This medicinal product is not recommended for emergencies. It can only
be used as a preventive treatment.

Productkenmerken

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Aspirin 75mg Gastro-resistant Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each gastro-resistant tablet contains 75mg acetylsalicylic acid.
Excipient with known effect
Each gastro resistant tablet contains 0.0016 mg sodium (Essentially
‘sodium-free’).
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Gastro-resistant tablet.
75 mg: Oval, white, biconvex film-coated tablets, 9.2 x 5.2 mm.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
•
Secondary prevention of myocardial infarction.
•
Prevention of cardiovascular morbidity in patients suffering from
stable angina
pectoris.
•
History of unstable angina pectoris, except during the acute phase.
•
Prevention of graft occlusion after Coronary Artery Bypass Grafting
(CABG).
•
Coronary angioplasty, except during the acute phase.
•
Secondary
prevention
of
transient
ischaemic
attacks
(TIA)
and
ischaemic
cerebrovascular
accidents
(CVA),
provided
intracerebral
haemorrhages
have
been ruled out.
Aspirin 75mg Gastro-resistant Tablets is not recommended in emergency
situations. It
is restricted to secondary prevention with chronic treatment.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Adults
_Secondary prevention of myocardial infarction: _
The recommended dose is 75-160 mg once daily.
_Prevention of cardiovascular morbidity in patients suffering from
stable angina _
_pectoris: _
The recommended dose is 75-160 mg once daily.
_History of unstable angina pectoris, except during the acute phase: _
The recommended dose is 75-160 mg once daily.
_Prevention of graft occlusion after Coronary Artery Bypass Grafting
(CABG): _
The recommended dose is 75-160 mg once daily.
_Coronary angioplasty, except during the acute phase: _
The recommended dose is 75-160 mg once daily.
_Secondary _
_prevention _
_of _
_transient _
_ischaemic _
_attacks _
_(TIA) _
_and _
_ischaemic _
_cerebrovascular accidents (CVA), provided intracerebral haemorrhages
have been _
_ruled out: _
The recommende